Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangfeng Shen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Life Sciences|June 12, 2020
Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancerXiangfeng Shen, Yuan Zhao, Guolong Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 9, 2017
CLDN6 promotes chemoresistance through GSTP1 in human breast cancerMinlan Yang, Yanru Li, Xiangfeng Shen, et al.
International Journal of Biological Sciences|April 4, 2017
BEX2 promotes tumor proliferation in colorectal cancerYeting Hu, Qian Xiao, Haiyan Chen, et al.
Nature Communications|December 17, 2025
Loss of ALK4 promotes cancer progression through regulating TGF-β receptor N-glycosylationManqi Zhang, Jian Chen, Mary C Leupold, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Life Sciences|June 12, 2020
Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancerXiangfeng Shen, Yuan Zhao, Guolong Liu, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 9, 2017
CLDN6 promotes chemoresistance through GSTP1 in human breast cancerMinlan Yang, Yanru Li, Xiangfeng Shen, et al.
International Journal of Biological Sciences|April 4, 2017
BEX2 promotes tumor proliferation in colorectal cancerYeting Hu, Qian Xiao, Haiyan Chen, et al.
Nature Communications|December 17, 2025
Loss of ALK4 promotes cancer progression through regulating TGF-β receptor N-glycosylationManqi Zhang, Jian Chen, Mary C Leupold, et al.
Pageof 2